Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2025-12-26 @ 2:49 AM
NCT ID: NCT01104402
Description: None
Frequency Threshold: 0
Time Frame: 12 months
Study: NCT01104402
Study Brief: Early Intervention in Cystic Fibrosis Exacerbation
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Standard Care Subjects will receive education about signs and symptoms indicative of worsening CF. None None 3 132 47 132 View
Home Monitoring Subjects will be randomized to monitor home spirometry and symptoms using a handheld device. Home lung function and symptom monitoring: subjects in the intervention arm will measure spirometry and CF symptoms with the use of a handheld device. None None 4 135 53 135 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Exacerbation of Cystic Fibrosis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
sputum increased SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View